The fungal genus Paecilomyces comprises numerous pathogenic and saprobic species, which are regularly isolated from insects, nematodes, soil, air, food, paper and many other materials. Some of the Paecilomyces species have been known to exhibit capabilities for curing human diseases. Here, bioactivities of metabolites from some soil inhabitant and invertebrate pathogenic Paecilomyces species were explored against a panel of target prokaryotic and eukaryotic microorganisms. First, Petri plate assays indicated that all tested Paecilomyces species were capable of producing diffusible metabolites and volatile compounds with antifungal activities against Pyricularia oryzae and Saccharomyces cerevisiae. Subsequently, the metabolites of the Paecilomyces species were extracted and the growth inhibitory and antimitotic effects of extra-cellular metabolites were shown using the yeast S. cerevisiae as a model. . These findings indicate that the Paecilomyces species, either saprobic or pathogenic, have a strong arsenal of bioactive metabolites which show inhibitory or cytotoxic effects against other microorganisms, with a potential for application in agroforestry and medicine.
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The discovery of new biologically active secondary metabolites is of very high interest for both agrochemical and pharmaceutical bioindustries. Secondary metabolites (SM) are small bioactive molecules produced by many organisms specially plants, fungi and bacteria. These compounds are particularly abundant in the soil-dwelling microorganisms, which exist as multicellular communities competing with each other for ecological niches, nutrients, minerals and water. Among these, filamentous fungi are well established sources for such substances (Keller et al., 2005) .
Soil represents one of the main reservoirs of filamentous fungi. The fungal genus Paecilomyces comprises numerous pathogenic and saprobic species, which are regularly isolated from insects, nematodes, soil, air, food, paper and many other materials (Aguilar et al., 1998; Fiedler and Sosnowska, 2007; Gupta et al., 1993; O'Day, 1977; Marti et al., 2006; Saberhagen et al., 1997; Tigano-Milani, et al., 1995; Westenfeld, et al., 1996) . Although, there has been no comprehensive review of the genus yet, more than forty species have been recognized in the genus Paecilomyces (Luangsaard et al., 2004) . A number of Paecilomyces species are known to produce a scintillating array of bioactive secondary metabolites of different chemical classes and with different biological activities (Wang et al., 2002) .
Currently, sustainable agriculture is demanding innovative and environmentally friendly procedures to protect plants against biotic stresses. Moreover, there is an ongoing need for novel sources of bioactive metabolites for the treatment of human infections and cancer diseases. Some of the Paecilomyces species have been known to exhibit promising capabilities for curing diseases of human being (Furuya et al., 1983; Manabe et al., 1996; Choi et al., 1999) . However, little is known about the biological activities of pathogenic Paecilomyces species that infect invertebrate organisms such as insects and nematodes. Here, antifungal, antimicrobial and antiproliferative activities of secondary metabolites from a few soil inhabitant and invertebrate pathogenic Paecilomyces species are explored against a panel of target prokaryotic and eukaryotic microorganisms.
Materials and Methods
Paecilomyces fungal species
The soliborne fungi Paecilomyces variotii, Paecilomyces lilacinus S1, and Paecilomyces fumoroseus isolated from the soil samples (Jamali and Banihashemi, Shiraz University, Fars, Iran, unpublished), the nematophagous Paecilomyces lilacinus N1 isolated from the potato cyst nematode Globodera rostochiensis (Giti M., Agriculture Research Center, Hamedan, Iran, unpublished) and the entomopathogenic Paecilomyes sp.1 and Paecilomyces sp.2 isolated from the Colorado potato beetles Leptinotarsa decemlineata (Say) (Assadollahpour et al., 2011) were obtained as pure cultures. The isolates were subcultured onto Potato Dextrose Agar (PDA) medium (Merck Co., Germany) and stored at 4 ºC.
Target microorganisms and culture condition
The bioactivity of Paecilomyces species were tested on a number of model target fungi and bacteria, in vitro. The filamentous fungus Pyricularia oryzae HS-1390 (HosseyniMoghaddam and ) served as a model target in antifungal experiments. The fungus was brought into pure culture and maintained on PDA culture medium at 4 ºC. The budding yeast Saccharomyces cerevisiae PTCC5269 was also used as a model target for antifungal and antiproliferative/cytotoxicity assays. The yeast isolate was maintained on Yeast Extract-Peptone-Dextrose-Agar (YPDA) culture medium.
The target bacteria included six human pathogenic bacteria, i.e. the gram-positive bacteria Staphylococcus aureus PTCC118, Bacillus subtilis PTCC1159, Streptococcus pyogenes PTCC1447, and the gram-negative bacteria Escherichia coli PTCC1399, Pseudomonas aeruginosa PTCC1181 and Salmonella typhi PTCC1609. The strains were periodically subcultured on Nutrient Agar (NA) medium and stored at 4 ºC.
Antifungal bioassays using Pyricularia oryzae
Pyricularia oryzae HS-1390 was initially used as a model target to screen for antifungal activity of Paecilomyces species. The anti-P. oryzae activity of Paecilomyces species was examined in two manners. First, a dual culture of each Paecilomyces isolate and P. oryzae was performed on PDA Petri plates at 28ºC. Daily mycelia growth of P. oryzae, in the presence of each Paecilomyces isolate was compared to that of control. After 10 days, the diameter (D) of the inhibition zone was measured (mm) and growth inhibition rate was calculated by the following formula: Growth inhibition rate (%) = (D control -D treated / D control) × 100.
Second, the effect of volatile compounds (VOC) produced by Paecilomyces isolates were examined on the mycelia growth of P. oryzae, in vitro. To this end, each Paecilomyces isolate, as well as, the target P. oryzae were subcultured simultaneously on separate PDA Petri plates. The caps of Petri plates were removed and the plates were put on each other and sealed by parafilm. Daily mycelia growth of P. oryzae, was compared to that of control, and after 8 days, the diameter (D) of the inhibition zone was measured (mm) as explained before.
Antifungal bioassays using Saccharomuces cerevisiae
The budding yeast Saccharomyces cerevisiae PTCC5269 was also used as a model target in antifungal bioassays. The anti-yeast activity of Paecilomyces species was examined in two manners. First, a bilayer culturing system was applied. For this, each Paecilomyces species was cultured on a PDA Petri plate and incubated at 28 ºC for 10 days, until the hyphae covered 3/4 of the Petri plate. Then a cooled YPDA culture medium was poured on each Paecilomyces culture to make a bilayer culture medium, and was let be solidified. Then, the Petri plates were incubated at 28 ºC for 24 hours to let the Paecilomyces metabolites diffuse in the upper YPDA layer. Subsequently, the yeast cells were spread over the YPDA layer, and the plates were incubated at 28 ºC for 18 hours. The emergence and growth of yeast colonies were evaluated compared to the control plates in a quantifiable manner.
Second, the effect of volatile compounds (VOC) produced by Paecilomyces isolates were examined on the emergence and growth of yeast colonies, in vitro. To this end, each Paecilomyces isolate was subcultured on a separate PDA Petri plate, and let grow and cover the whole plate. When, the yeast was cultured on YPDA, the caps of Petri plates were removed and the Paecilomyces plates were put on each yeast plate and sealed by parafilm. After 24 hours at 28 ºC the emergence and growth of yeast colonies were compared to that of control. The experiment was repeated two times.
Intra-and extra-cellular metabolite extraction from Paecilomyces species
The fresh Paecilomyces species were inoculated into Potato Dextrose Broth (PDB) in Erlenmeyer flasks and incubated for 12 days at 28 ºC, 120 rpm, under dark condition. After the fermentation processes, each individual culture broth was extracted with methanol (MeOH).
To obtain extracellular metabolites, the fermentation broth was filtered. Then, equal volumes of the organic solvent MeOH (1:1) was added to each individual culture broth. The extract was transferred to 4 ºC for 12 hours to remove waxy materials. Subsequently, the solvent was removed by evaporation under 50 ºC. The dried MeOH extracts were re-dissolved in double distilled water or DMSO to obtain a final concentration of 250 mg ml -1
. Finally, the concentrated extracts were passed through a filtration membrane (d = 0.22 μm) before their bioactivities were assayed.
To obtain intracellular metabolites, the fresh Paecilomyces species were inoculated into Potato Dextrose Broth (PDB) in Erlenmeyer flasks (2 liter) and incubated for 30 days at 28ºC, the mycelia biomasses were harvested, thoroughly washed, and were macerated in MeOH (1:5, 2 days). Then the mycelia were homogenized thoroughly. The supernatants were further treated as explained above for the extracellurar metabolites.
Until used for bioassays, the secondary metabolites were kept at -20 ºC.
Antimitotic/cytotoxic bioassays
Saccharomyces cerevisiae was recruited as a model target microorganism to screen for antimitotic/cytotoxic activity of Paecilomyces extracellular metabolites. For this, the S. cerevisiae was grown overnight in YPD broth medium to obtain 1.5 × 10 8 CFU mL -1
. A 5 mL aliquot was seeded into each well of a 96 well microtiter plate containing 95 µl YPD. The sample extract (100 µL) was added to each well in a serially diluted manner to yield the final concentrations of 100, 50, 25 and 15 mg mL -1 . The assay plates were incubated at 27 ºC for 24 h. The growth of yeast was observed and compared with that of the control to determine the minimum inhibitory concentration (MIC) and the minimum fungicidal concentration (MFC). The experiments were performed in triplicate and were repeated three times.
Moreover, to track the cell number changes, S. cerevisiae (1.5 × 10 8 CFU.mL) was seeded (250 μL) into test tubes containing 10 mL YPD. Then, the sample extract (1 mL) was added to each test tube in a serially diluted manner to yield the final concentrations of 100, 50, 25 and 15 mg mL -1
. The assay tubes were incubated at 27 ºC for 18 h, 120 rpm. The experiments were followed as described above. The growing numbers of yeast cells (OD 620 ) were recorded at OD 620 .
Antimicrobial bioassays
Six human pathogenic bacteria were employed as model target bacteria in our antimicrobial assays, as mentioned above. Extra-cellular secondary metabolites from Paecilomyces isolates were evaluated for their antimicrobial bioactivities. For this, bacteria were grown overnight in Nutrient Broth (NB) medium to obtain 1.5 × 10 8 CFU ml -1
. Then, 5 mL bacterial suspensions were seeded into each well of a 96 well microtiter plate that contained 95 µl of Nutrient Broth medium. The extracellular extract (100 µl) was added to each well in a serially diluted manner to yield the final concentrations of 100, 50, 25.15 mg ml -1 . The assay plates were incubated at 37 ºC for 24 h. The growth of target bacteria was observed and compared with that of the control to determine the minimum bactericidal concentration (MBC) and the minimum inhibitory concentration (MIC). The experiments were performed in triplicate and were repeated three times.
Statistical analysis
SAS procedure and programs were used for statistical analysis. In case where the F-test showed significant differences among means, the differences among treatments were compared using least significant differences (LSD) test at 1% significance level.
Results
Antifungal activity of Paecilomyces species against Pyricularia oryzae
The rice blast pathogen Pyricularia oryzae is used as a model target for primary screening of antitumor and antifungal agents (Kobayashi et al. 1996 , Dong et al., 2008 Xu et al., 2009; HosseyniMoghaddam and Soltani, 2014a, 2014b; Pakvaz and Soltani, 2016; Soltani and HosseyniMoghaddam, 2014a , 2015 Soltani et al., 2016) . As shown in Table 1 , all Paecilomyces isolates inhibited the mycelial growth of the model fungus P. oryzae, in Petri plate dual culture assays. However, Paecilomyces variotii and P. lilacinus isolates were significantly more bioactive (54.3-61% growth inhibition) than the other isolates in this assay.
We further investigated the potential of volatile compounds (VOCs) production by Pecilomyces isolates and their possible biological effects. As shown in Table 2 , all Pecilomyces isolates produced bioactive volatile compounds which inhibited the mycelia growth of the model fungus P. oryzae, in Petri plate assays. However, volatile compounds produced by Paecilomyces variotii and P. lilacinus S1 were significantly more bioactive than the other isolates (53.5-68% growth inhibition) in this assay.
Antifungal activity of Paecilomyces species against the yeast Saccharomyces cerevisiae
The antifungal activity of the Paecilomyces isolates against the yeast was shown in two ways. First, the bilayer technique indicated that the diffusible metabolites of the Paecilomyces isolates moderately inhibited the emergence and growth of yeast colonies (Table 3) . However, the metabolites of Paecilomyces lilacinus S1, Paecilomyces fumoroseus and Paecilomyces sp.2 were more bioactive than the others in this assay.
Second, the inhibitory effects of volatile compounds (VOCs) produced by Pecilomyces isolates was shown, in vitro, on yeast. Observations indicated that all Pecilomyces species were capable of producting bioactive VOCs (Table 4) . However, the VOCs of Paecilomyces fumoroseus were more bioactive than the other isolates, and severely decreased the emergence and growth of yeast colonies. Anti-fungal and anti-mitotic bioactivities of intra-and extra-cellular Pecilomyces metabolites tested on the yeast Saccharomyces cerevisiae The budding yeast Saccharomyces cerevisiae (an ascomycetous fungus) was used in our assays as a model target organism to test for Paecilomyces isolates metabolite bioactivity. The concentrations of 5, 15, 25, 50 and 100 mg mL -1 of the intra-and extra-cellular metabolites from Paecilomyces isolates were investigated for their MIC and MFC efficiencies against the yeast S. cerevisiae. As shown in Table 5 , except for Paecilomyces sp.1, at the provided concentrations the intra-cellular metabolites of Paecilomyces isolates didn't show any anti-yeast activity. However, the extra-cellular metabolites of all isolates showed inhibitory activities against S. cerevisiae, mainly at MIC concentrations of 50 mg mL -1
. Moreover, only the extra-cellular metabolites of Paecilomyces sp.1 had a fungicidal effect against S. cerevisiae, at an MFC concentration of 50 mg mL -1 . Accordingly, the antimitotic bioactivity of extra-cellular metabolites from Paecilomyces isolates was investigated, as measured by the growing numbers of yeast cells (OD 620 ) after 18 hours of incubation at 27 °C. As shown in Table 6 , all extra-cellular metabolites showed some degree of the antimitotic/cytotoxic activities. However, at the lowest metabolite concentrations of 15 and 25 mg mL -1 , the isolates Paecilomyces variotii, Paecilomyces lilacinus S1, and Paecilomyces sp.2 showed the most potent antimitotic activities. Increasing the metabolite concentration increased the antimitotic/cytotoxic activity. In this regard, the highest cytotoxic activity (87.1%) was seen for the 100 mg mL -1 concentration of Paecilomyces lilacinus S1 metabolite.
Antibacterial activity of extra-cellular metabolites from Pecilomyces species
Antimicrobial activities of extra-cellular Pecilomyces metabolites (5, 15, 25, 50 and 100 mg mL -1 ) were further tested on six bacterial species, i.e. B. subtilis, S. aureus, S. pyogenes E. coli, P. aeruginosa, and S. typhi. The results of MIC and MBC experiments are presented in Table 7 . As seen, in the range of the provided metabolite concentrations all extracts showed inhibitory effects. The results of MIC experiments indicated that, in general, the extra-cellular extracts of Paecilomyces sp.1 and Paecilomyces sp.2 could inhibit the growth of the target bacteria at lower concentrations than the other species. The highest MICs were observed for the metabolites of P. variotii and Paecilomyces sp.1 against E. coli and B. subtilis, respectively (Table 7) .
However, as the results of MBC experiments indicated (Table 7) , the extra-cellular extracts were rarely bactericidal in the range of the provided metabolite concentrations. In this respect, the metabolites of P. variotii and Paecilomyces sp.2 showed bactericidal activities at 25 and 50 mg mL -1 against P. aeruginosa and E. coli, respectively. 
Discussion
Recently, fungal secondary metabolites have attracted considerable attention from the scientific community (Shwab and Keller, 2008) . The fungal genus Paecilomyces, which is widespread in nature, has adapted different life styles as saprobic, endophytic, enthomopathogenic, mycoparasitic, nematophagous, as well as opportunistic human pathogen (Aguilar et al., 1998; Fiedler and Sosnowska, 2007; Gupta et al., 1993; O'Day, 1977; Marti et al., 2006; Saberhagen et al., 1997; Tigano-Milani, et al., 1995; Westenfeld, et al., 1996) . Paecilomyces species are of high interest in agrobioindustry for biological control of insects and plant pathogenic nematodes (Anonymous, 2016) . Furthermore, some Paecilomyces species are capable of producing cytotoxic metabolites with potential application in cancer therapy (Huang et al., 2001; Shim et al., 2000; Xu et al., 2009) . Here, we aimed at evaluating the potential of several soliborne, entomopathogenic and nematophagous Paecilomyces species for the production of secondary metabolites with antifungal, antibacterial and antimitotic activities.
Our data indicated that the Paecilomyces species were highly bioactive against the filamentous fungus Pyricularia oryzae and the yeast Saccharomyces cerevisiae, as they produced diffusible metabolites and volatile compounds with strong inhibitory effects against these model target fungi (Tables 1-4 ).
This indicated the promising potential of Paecilomyces secondary metabolites as antifungal agents. Then, intra-and extracellular metabolites of the Paecilomyces species were extracted and applied against a range of target fungi and bacteria. Data indicated that in contrary to intra-cellular metabolites, the extracellular metabolites of all Paecilomyces species inhibited the growth of S. cerevisiae at concentrations of 50 mg mL -1 (Table 5) . At this concentration, the extra-cellular metabolite of Paecilomyces sp.1 also exerted fungicidal effect. Moreover, based on the growing numbers of yeast cells, all extra-cellular metabolites showed some degrees of the antimitotic/cytotoxic activity (Table 6 ). Hence, the extra-cellular metabolites of the Paecilomyces species were capable of both antifungal and antimitotic activities.
Furthermore, the antibacterial effects of the Paecilomyces extra-cellular metabolites were demonstrated against a panel of gram-positive and gram-negative human pathogens. Indeed, at the provided concentrations most extracts inhibited the growth of bacteria, but rarely had bactericidal activity (Table 7) .
Taken all together, our findings indicate that the Paecilomyces species, either saprobic or pathogenic, have a strong arsenal of bioactive metabolites which show inhibitory or cytotoxicity effects against other microorganisms. Among these, P. variotii is a common environmental fungus that is widespread in composts, soils and food products, and has been emerged as an opportunistic human pathogen (Pitt and Hocking, 2009; Steiner et al., 2011) . Paecilomyces lilacinus colonizes a wide range of habitats including solis, insects, nematodes and is an infrequent cause of human disease (Domsch et al., 2007; Saberhagen et al. 1997) . Paecilomyces fumoroseus is an entomophatogenic fungus, infecting over twenty five different families of insects and many species of mites, and is in use as a biocontrol agent (Zimmermann, 2008) . In agreement with this diverse range of lifestyles and bioactivities, our finding further supports and extends the scope of Paecilomyces bioactivity against microorganisms such as pathogenic fungi and bacteria, as well. Such antifungal, antibacterial and antimitotic activities could find application in agroforestry, medicine, and bioindustry. Future research has to investigate the molecular and chemical basis behind these bioactivities.
